首頁 > 市場調查報告書 > 製藥

醫學影像診斷劑市場規模、佔有率及成長分析（按類型、模式、技術、應用和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900647

醫學影像診斷劑市場規模、佔有率及成長分析（按類型、模式、技術、應用和地區分類）－2026-2033年產業預測

Medical Imaging Reagents Market Size, Share, and Growth Analysis, By Class (Contrast reagents, Optical reagents), By Modality (X-ray, CT Scan), By Technology, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，醫療影像診斷劑市場規模將達到 182.5 億美元，到 2025 年將達到 192 億美元，到 2033 年將達到 288 億美元，預測期（2026-2033 年）的複合年成長率為 5.2%。

全球醫學影像診斷劑市場是醫療保健產業的重要組成部分，為診斷和檢查提供關鍵工具。這些試劑能夠增強磁振造影（MRI）、電腦斷層掃描（CT）、超音波和核子醫學等影像技術中特定組織和器官的對比和可見度。推動市場發展的關鍵因素包括慢性病發病率的上升、人口老化以及對早期精準疾病診斷日益成長的需求。醫學影像診斷劑顯著提高了診斷準確性和治療方案的製定，從而有助於改善患者的治療效果。分子成像技術正蓬勃發展，這需要能夠靶向特定分子以更好地表徵疾病的先進試劑。目前，研究人員正在不斷開發安全且高效的試劑，而混合成像系統也推動了適用於多種成像模式的多功能解決方案的需求。

醫學影像診斷劑市場促進因素

癌症、心血管疾病和神經系統疾病等慢性疾病發生率的不斷上升，顯著推動了對醫學成像技術的需求。在此背景下，醫學診斷劑至關重要，因為它們能夠提高診斷成像過程的準確性和有效性。這些改進轉化為更好的患者預後，促使醫療機構更廣泛地採用這些試劑。因此，對先進成像解決方案的需求持續成長，推動了醫學影像診斷劑市場的擴張。這一趨勢反映了透過提升診斷能力來改善醫療服務的更廣泛努力。

醫療影像診斷劑市場的限制

由於PET和MRI等先進影像技術高成本，醫學影像診斷劑市場面臨巨大的限制。這些試劑連同相關設備和醫療服務，給醫療機構和患者都帶來了沉重的經濟負擔。這種經濟挑戰可能會阻礙市場成長，尤其是在低收入地區和此類技術普及率較低的地區。這些成像診斷劑的高昂價格可能會阻礙其廣泛應用，並導致醫療品質的差異，從而限制不同族群醫學影像技術的發展。

醫療影像診斷劑市場趨勢

受分子造影劑（尤其是用於正子斷層掃描 (PET) 和單光子發射電腦斷層掃描 (SPECT) 的放射性藥物）需求不斷成長的驅動，醫學成像診斷劑市場正經歷著顯著的變革。這些先進的試劑增強了我們在分子和細胞層面上可視化和量化生物過程的能力，從而顯著改善了疾病的早期檢測、治療方案製定和後續觀察。放射性藥物研發的持續進展，尤其是在開發更具標靶性和特異性的藥物方面，進一步加速了這一趨勢。隨著醫療保健越來越重視精準醫療，對創新診斷劑的需求預計將會成長，從而塑造未來醫學診斷的格局。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

GE Healthcare（USA）
Siemens Healthineers（Germany）
Bracco Imaging SpA（Italy）
Bayer AG（Germany）
Guerbet Group（France）
Lantheus Holdings Inc.（USA）
Jubilant Radiopharma（India）
Cardinal Health Inc.（USA）
Nordion（Canada）Inc.（Canada）
Curium Pharma（France）
Advanced Accelerator Applications（AAA）-A Novartis Company（Switzerland）
Eli Lilly and Company（USA）
Thermo Fisher Scientific Inc.（USA）
PerkinElmer Inc.（USA）
Agfa-Gevaert Group（Belgium）
Merck KGaA（Germany）
Triad Isotopes Inc.（USA）
Nihon Medi-Physics Co. Ltd.（Japan）
Shenzhen Mindray Bio-Medical Electronics Co. Ltd.（China）
EczacIbasI-Monrol Nuclear Products（Turkey）

結論與建議

簡介目錄

Product Code: SQMIG35A2744

Medical Imaging Reagents Market size was valued at USD 18.25 Billion in 2024 and is poised to grow from USD 19.2 Billion in 2025 to USD 28.8 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The global medical imaging reagents market is an essential component of the healthcare sector, providing vital tools for diagnostics and research. These reagents enhance the contrast and visibility of specific tissues or organs in imaging techniques such as MRI, CT, ultrasound, and nuclear medicine. Key market drivers include the rising prevalence of chronic diseases, an increasing aging population, and the demand for early and accurate disease diagnosis. Medical imaging reagents significantly improve diagnostic accuracy and treatment planning, thereby facilitating better patient outcomes. There is a notable trend towards molecular imaging techniques, which require advanced reagents targeting specific molecules, enhancing disease characterization. Ongoing research aims to develop safer, more efficient reagents, while hybrid imaging systems are catalyzing demand for versatile solutions applicable across multiple imaging modalities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Medical Imaging Reagents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Medical Imaging Reagents Market Segments Analysis

Global Medical Imaging Reagents Market is segmented by Class, Modality, Technology, Application and region. Based on Class, the market is segmented into Contrast reagents, Optical reagents and Nuclear reagents. Based on Modality, the market is segmented into X-ray, CT Scan, Ultrasound and MRI Scan. Based on Technology, the market is segmented into Nanoparticles, Fluorescent dyes & probes, Radiopharmaceuticals, Fluorescent proteins and Quantum dots. Based on Application, the market is segmented into Diagnostics, Drug discovery & development and Educational Research. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Medical Imaging Reagents Market

The rising incidence of chronic illnesses such as cancer, cardiovascular disorders, and neurological conditions has significantly heightened the demand for medical imaging techniques. Within this context, medical imaging reagents are essential, as they enhance both the precision and effectiveness of diagnostic imaging processes. This enhancement leads to improved patient outcomes and encourages healthcare providers to adopt these reagents more widely. As a result, the need for advanced imaging solutions continues to grow, driving the expansion of the medical imaging reagents market. This trend reflects a broader commitment to improving healthcare delivery through enhanced diagnostic capabilities.

Restraints in the Medical Imaging Reagents Market

The medical imaging reagents market faces a significant constraint due to the high costs associated with advanced imaging techniques such as PET and MRI. These reagents, along with the equipment and related healthcare services, present a considerable financial burden for both healthcare facilities and patients. This economic challenge can hinder market growth, particularly in regions with lower income levels, where access to such technologies is limited. The expensive nature of these imaging reagents impedes widespread adoption and may lead to disparities in healthcare quality, thereby potentially restricting advancements in medical imaging practices across various demographics.

Market Trends of the Medical Imaging Reagents Market

The Medical Imaging Reagents market is witnessing a notable shift driven by the growing demand for molecular imaging agents, particularly positron emission tomography (PET) and single-photon emission computed tomography (SPECT) radiopharmaceuticals. These advanced reagents enhance the ability to visualize and quantify biological processes at the molecular and cellular levels, significantly improving early disease detection, treatment planning, and monitoring. Continuous advancements in radiopharmaceutical development, focusing on the creation of more targeted and specific agents, are further fueling this trend. As healthcare increasingly prioritizes precision medicine, the need for innovative imaging reagents is expected to rise, thereby shaping the future landscape of medical diagnostics.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis

Global Medical Imaging Reagents Market Size by Class & CAGR (2026-2033)

Market Overview
Contrast reagents
Optical reagents
Nuclear reagents

Global Medical Imaging Reagents Market Size by Modality & CAGR (2026-2033)

Market Overview
X-ray
CT Scan
Ultrasound
MRI Scan

Global Medical Imaging Reagents Market Size by Technology & CAGR (2026-2033)

Market Overview
Nanoparticles
Fluorescent dyes & probes
Radiopharmaceuticals
Fluorescent proteins
Quantum dots

Global Medical Imaging Reagents Market Size by Application & CAGR (2026-2033)

Market Overview
Diagnostics
Drug discovery & development
Educational Research

Global Medical Imaging Reagents Market Size & CAGR (2026-2033)

North America (Class, Modality, Technology, Application)
- US
- Canada
Europe (Class, Modality, Technology, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Class, Modality, Technology, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Class, Modality, Technology, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Class, Modality, Technology, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bracco Imaging S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guerbet Group (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lantheus Holdings Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Radiopharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nordion (Canada) Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curium Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Accelerator Applications (AAA) - A Novartis Company (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agfa-Gevaert Group (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Triad Isotopes Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Medi-Physics Co. Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EczacIbasI-Monrol Nuclear Products (Turkey)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments